Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Endocrinology

Background:

• The vitamin D receptor (VDR) plays a crucial role in calcium homeostasis and cell proliferation.
• Developing VDR ligands with selective activity is essential for therapeutic applications, minimizing side effects like hypercalcemia.

Purpose of the Study:

• To synthesize and evaluate novel nonsecosteroidal VDR ligands with a phenyl-pyrrolyl pentane skeleton.
• To identify compounds with potent VDR agonistic activity and antiproliferative effects, while lacking calcemic activity.

Main Methods:

• Synthesis of novel nonsecosteroidal analogs.
• In vitro evaluation of VDR binding affinity and antiproliferative activity in HaCaT and MCF-7 cell lines.
• In vivo assessment of serum calcium levels in a control study using tacalcitol.

Main Results:

• Several synthesized compounds demonstrated VDR agonistic and antiproliferative activities.
• Compound 2g exhibited significantly higher VDR agonistic activity (EC₅₀: 1.06 nM) compared to tacalcitol (EC₅₀: 7.05 nM).
• Compound 2g inhibited cell proliferation effectively but showed no significant impact on serum calcium levels.

Conclusions:

• Novel nonsecosteroidal phenyl-pyrrolyl pentane analogs represent a promising class of VDR ligands.
• Compound 2g is a potent VDR agonist with separated calcemic activity, suggesting therapeutic potential for VDR-related conditions.